Financhill
Back

Novavax Quote, Financials, Valuation and Earnings

Sell
39

NVAX
Novavax

Last Price:
16.51
Seasonality Move:
18.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Novavax Price Quote

$16.51
-0.01 (-2.02%)
(Updated: December 3, 2022 at 4:29 AM ET)

Novavax Key Stats

Sell
39
Novavax (NVAX) is a Sell

Day range:
$15.53 - $16.55
52-week range:
$15.53 - $236.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.54
P/B ratio:
0%

Volume:
6.2M
Avg. volume:
4.8M
1-year change:
-89.8%
Market cap:
$1.3B
Revenue:
$1.1B
EPS:
$-17.3

How Much Does Novavax Make?

  • How Much Are Novavax's Sales Annually?
    NVAX Revenues are $1.1B
  • How Much Profit Does Novavax's Make A Year?
    NVAX net income is -$1.7B

Is Novavax Growing As A Company?

  • What Is Novavax's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 13.33%
  • What Is Novavax's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Novavax Stock Price Performance

  • Did Novavax Stock Go Up Last Month?
    Novavax share price went down by -19.41% last month
  • Did NVAX's Share Price Rise Over The Last Year?
    NVAX share price fell by -89.8% over the past 1 year

What Is Novavax 52-Week High & Low?

  • What Is Novavax’s 52-Week High Share Price?
    Novavax has traded as high as $236.50 over the past 52 weeks
  • What Is Novavax’s 52-Week Low Share Price?
    Novavax has traded as low as $15.53 over the past 52 weeks

Novavax Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Novavax?

  • How Much Debt Does Novavax Have?
    Total long term debt quarterly is $324.5M
  • How Much Cash Does Novavax Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Novavax’s Book Value Per Share?
    Book value per share is -7.21

Is Novavax Cash Flow Positive?

  • What Is NVAX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$640.5M
  • What Is Novavax’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $72.8M
  • What Is Novavax’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$87.3M

Novavax Return On Invested Capital

  • Is Management Doing A Good Job?
    NVAX return on invested capital is -814.91%
  • What Is Novavax Return On Assets?
    ROA measures how assets are converting to revenues and is -51.37%
  • What Is NVAX Return On Equity?
    ROE is a measure of profitability and is 0%

Novavax Earnings Date & Stock Price

  • What Is Novavax's Stock Price Today?
    A single share of NVAX can be purchased today for 16.52
  • What Is Novavax’s Stock Symbol?
    Novavax trades on the nasdaq under the ticker symbol: NVAX
  • When Is Novavax’s Next Earnings Date?
    The next quarterly earnings date for Novavax is scheduled on February 28, 2023
  • When Is NVAX's next ex-dividend date?
    Novavax's next ex-dividend date is December 4, 2022
  • How To Buy Novavax Stock?
    You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Novavax Competitors

  • Who Are Novavax's Competitors?
    Below is a list of companies who compete with Novavax or are related in some way:
    • Inovio Pharmaceuticals Inc (INO)
    • Johnson & Johnson (JNJ)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)

Novavax Dividend Yield

Data Unavailable

Novavax Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -235.01%
Revenue: 1333.27% 32.24%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 78.17
Upside from Last Price: 373.16%

Major Shareholders

  • How many NVAX shares are owned by institutional investors?
    51.5M NVAX shares are owned by institutional investors
  • How many NVAX shares are owned by insiders?
    1.8M NVAX shares are owned by insiders